For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Veracyte Inc (NASDAQ: VCYT) closed at $37.34 in the last session, up 2.05% from day before closing price of $36.59. In other words, the price has increased by $2.05 from its previous closing price. On the day, 1.93 million shares were traded. VCYT stock price reached its highest trading level at $41.43 during the session, while it also had its lowest trading level at $37.285.
Ratios:
We take a closer look at VCYT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.78. For the most recent quarter (mrq), Quick Ratio is recorded 4.79 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on October 16, 2024, initiated with a Buy rating and assigned the stock a target price of $43.
On October 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $40.
Needham reiterated its Buy rating for the stock on February 23, 2024, while the target price for the stock was revised from $30 to $33.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 19 ’24 when JONES EVAN/ FA sold 5,173 shares for $35.23 per share. The transaction valued at 182,263 led to the insider holds 0 shares of the business.
Leite John sold 5,479 shares of VCYT for $163,159 on Sep 04 ’24. The Chief Commercial Officer-CLIA now owns 76,174 shares after completing the transaction at $29.78 per share. On Sep 04 ’24, another insider, JOHN LEITE, who serves as the Officer of the company, bought 5,479 shares for $30.29 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 2868163584 and an Enterprise Value of 2621311488. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.74 while its Price-to-Book (P/B) ratio in mrq is 2.53. Its current Enterprise Value per Revenue stands at 6.163 whereas that against EBITDA is 81.478.
Stock Price History:
Over the past 52 weeks, VCYT has reached a high of $37.40, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is 12.56%, while the 200-Day Moving Average is calculated to be 45.34%.
Shares Statistics:
According to the various share statistics, VCYT traded on average about 853.72K shares per day over the past 3-months and 674170 shares per day over the past 10 days. A total of 76.81M shares are outstanding, with a floating share count of 75.65M. Insiders hold about 1.51% of the company’s shares, while institutions hold 104.75% stake in the company. Shares short for VCYT as of 1728950400 were 3099723 with a Short Ratio of 3.63, compared to 1726185600 on 3496212. Therefore, it implies a Short% of Shares Outstanding of 3099723 and a Short% of Float of 4.5.
